A Study of Eloralintide (LY3841136) in Chinese Participants With Obesity or Overweight

Clinical trial NCT06916091 · COMPLETED

Trial details

NCT number: NCT06916091
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Obesity Overweight

Start date: 2025-04-21
Primary completion: 2025-09-09
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.